Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Praxis Precision Medicines I (PRAX)

289 + Investors. Track Smart Money conviction in PRAX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +42
Streak
3Q ▲
Buyers last Q
64%

Smart Money Signals — PRAX

Based on 295 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added PRAX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
295 hedge funds hold PRAX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +95% more funds vs a year ago

fund count last 6Q
+144 new funds entered over the past year (+95% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 64% buying

201 buying113 selling
Last quarter: 201 funds were net buyers (78 opened a brand new position + 123 added to an existing one). Only 113 were sellers (77 trimmed + 36 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-39 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 24 → 27 → 117 → 78. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔄

Mostly new holders — 51% entered in last year

■ 18% conviction (2yr+) ■ 31% medium ■ 51% new
Only 53 funds (18%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
🚀

Acceleration phase — new buyers rushing in

35 → 24 → 27 → 117 → 78 new funds/Q
New funds entering each quarter: 24 → 27 → 117 → 78. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 19% veterans, 52% new entrants

■ 19% veterans ■ 29% 1-2yr ■ 52% new
Of 306 current holders: 58 (19%) held 2+ years, 90 held 1–2 years, 158 (52%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 37% AUM from major funds

37% from top-100 AUM funds
53 of 286 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
6.0
out of 10
Moderate Exit Risk
Exit risk score 6.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PRAX

In 2026 Q1, 201 hedge funds were net buyers of PRAX (78 opened a new position, 123 added to an existing one), while 113 reduced or exited (77 trimmed, 36 sold completely) — a 64% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 37% of total institutional value in PRAX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +42 funds (more new holders than closures). Total institutional holders: 295.

Hedge Fund Ownership: PRAX

How many hedge funds hold PRAX — quarterly history vs. share price
Quarterly hedge fund ownership of PRAX vs. share price

Market Analysis: PRAX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PRAX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Praxis Precision Medicines I (PRAX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PRAX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 46d ago
PRAX
+9.6%
XLV
+5.5%

PRAX outperformed XLV by +4.1% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 1d ago
PRAX
+0.0%
XLV
+0.0%

Since the filing became public, PRAX outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

24 top-rated funds 13 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
4.6
/ 10
conviction
Hedge Fund Positioning: PRAX
2026 Q2 Stats Unlock in 4 days 289 + Investors

Track Smart Money conviction in PRAX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 289 252 14.68%
13F Shares 29M 31M -5.56%
Total Value $9.08B $8.83B 2.82%
New Positions 74 116 -42
Increased Positions 120 88 +32
Closed Positions 37 14 +23
Reduced Positions 73 45 +28
Total Calls 7 10 -30.0%
Total Puts 13 12 8.33%
PUT/CALL Ratio 1.86 1.2 Bearish

Statistics: PRAX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

289 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PRAX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 PRAX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 72 Investment Holdings, LLC 44.18% 65,933 $22.1M
2 Acuta Capital Partners, LLC 19.32% 82,796 $27.7M
3 Velan Capital Investment Management LP 18.10% 88,781 $29.7M
4 Cormorant Asset Management, LP 10.98% 640,000 $214.3M
5 KVP Capital Advisors, LP 10.54% 42,900 $14.4M
6 Perceptive Advisors LLC 10.23% 2,035,986 $681.6M
7 University of Wisconsin Foundation 9.21% 34,730 $11.6M
8 Vivo Capital, LLC 8.29% 271,116 $90.8M
9 Lion Point Capital, LP 7.13% 4,450 $1.5M
10 Exome Asset Management LLC 5.62% 27,205 $9.1M
11 Ishara Investments LP 5.55% 22,550 $7.5M
12 B Group, Inc. 5.22% 33,237 $11.1M
13 Logos Global Management LP 3.75% 260,000 $87.0M
14 Deerfield Management Company, L.P. 3.36% 963,351 $322.5M
15 First Turn Management, LLC 2.99% 83,528 $28.0M
16 Baker BROS. Advisors LP 2.94% 1,753,198 $587.0M
17 Affinity Asset Advisors, LLC 2.80% 185,000 $61.9M
18 Ikarian Capital, LLC 2.63% 72,842 $24.4M
19 HighVista Strategies LLC 2.31% 30,210 $10.1M
20 Silverarc Capital Management, LLC 2.29% 65,679 $22.0M
21 Stempoint Capital LP 2.15% 37,243 $12.5M
22 Soleus Capital Management, L.P. 2.05% 177,517 $59.4M
23 Driehaus Capital Management LLC 1.86% 959,048 $321.1M
24 683 Capital Management, LLC 1.82% 110,400 $37.0M
25 Orbis Allan Gray Ltd 1.76% 1,529,788 $512.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Praxis Precision Medicines I (PRAX)

What does the Smart Money Trend signal show for PRAX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added PRAX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PRAX?

More buyers than sellers — 64% buying: Last quarter: 201 funds were net buyers (78 opened a brand new position + 123 added to an existing one). Only 113 were sellers (77 trimmed + 36 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for PRAX holders?

Strong quality — 37% AUM from major funds: 53 of 286 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held PRAX?

Mostly new holders — 51% entered in last year: Only 53 funds (18%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Praxis Precision Medicines I (PRAX) following the 2026 Q2 hedge fund 13F filings?

As of today, PRAX has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), PRAX has gained +9.6% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →